NYSE:HP • US4234521015
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HELMERICH & PAYNE (HP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-02-10 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-09 | TD Cowen | Maintains | Hold -> Hold |
| 2026-02-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-01-07 | TD Cowen | Maintains | Hold -> Hold |
| 2026-01-07 | Susquehanna | Maintains | Positive -> Positive |
| 2025-12-18 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-12-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-11 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-10 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-11-25 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-11-25 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-11-21 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-11-20 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-19 | Susquehanna | Maintains | Positive -> Positive |
| 2025-11-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-10-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-06 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-22 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-08-19 | TD Cowen | Maintains | Hold -> Hold |
| 2025-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-15 | Piper Sandler | Initiate | Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.872B 39.51% | 2.757B -4.03% | 3.746B 35.89% | 4.105B 9.58% | 4.231B 3.07% | 4.329B 2.32% | 4.071B -5.96% | 4.062B -0.22% | 3.418B -15.85% | |
| EBITDA YoY % growth | 925.843M 114.67% | 848.055M -8.40% | 860.309M 1.44% | 892.7M 3.77% | 946.33M 6.01% | 1.002B 5.88% | 959.96M -4.20% | 941.42M -1.93% | 1.003B 6.54% | |
| EBIT YoY % growth | 543.529M 1,833.03% | 450.711M -17.08% | 235.224M -47.81% | 159.28M -32.29% | 261.26M 64.03% | 343.67M 31.54% | 208.06M -39.46% | 198.79M -4.46% | 636.54M 220.21% | |
| Operating Margin | 18.92% | 16.35% | 6.28% | 3.88% | 6.17% | 7.94% | 5.11% | 4.89% | 18.62% | |
| EPS YoY % growth | 4.15 4,050.00% | 3.49 -15.90% | 0.96 -72.64% | 0.36 -62.77% | 1.05 194.96% | 2.20 110.04% | 1.12 -49.03% | 0.98 -12.84% | 5.11 422.11% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 -70.57% | 0.15 -30.01% | 0.23 2,375.17% | 0.17 216.32% | 0.18 1,615.00% | 0.25 65.55% | 0.31 35.81% |
| Revenue Q2Q % growth | 980.24M -3.52% | 1.023B 0.31% | 1.049B 3.68% | 1.057B 3.93% | 977.76M -0.25% | 1.008B -1.47% | 1.031B -1.72% |
| EBITDA Q2Q % growth | 199.25M -37.92% | 222.63M -54.49% | 229.97M -64.55% | 230.26M 1.89% | 227.68M 14.27% | 238.56M 7.16% | 245.46M 6.74% |
| EBIT Q2Q % growth | 17.656M -72.51% | 43.582M -17.72% | 55.77M 135.82% | 45.938M 4.22% | N/A | N/A | N/A |
All data in USD
25 analysts have analysed HP and the average price target is 36.94 USD. This implies a price decrease of -0.03% is expected in the next year compared to the current price of 36.95.
HELMERICH & PAYNE (HP) will report earnings on 2026-05-05, after the market close.
The consensus EPS estimate for the next earnings of HELMERICH & PAYNE (HP) is 0.01 USD and the consensus revenue estimate is 980.24M USD.
The expected long term growth rate for HELMERICH & PAYNE (HP) is 4.29%.